100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
Summary Task 3 - Schizophrenia & violence CA$5.28   Add to cart

Summary

Summary Task 3 - Schizophrenia & violence

 5 views  0 purchase
  • Course
  • Institution

Summary of Task 3 of Neuropsychology & Law

Preview 2 out of 11  pages

  • September 27, 2023
  • 11
  • 2023/2024
  • Summary
avatar-seller
SCHIZOPHRENIA & VIOLENCE
WHAT IS SCHIZOPHRENIA? – SYMPTOMS, CAUSES, TREATMENT

SCHIZOPHRENIA (PICCHIONI)

WHAT IS SCHIZOPHRENIA?

 Hallucinations – typically auditory, may speak directly to the patient, comment on the
patient’s actions, or discuss the patient among themselves
 Making sense of hallucinations  strange beliefs / delusions
 Prevalence relatively high – often starts in early adult life & becomes chronic

WHO GETS SCHIZOPHRENIA?

 Presents in early adulthood / late adolescence
 Men have earlier onset than women & tend to experience more serious form of illness
 More common in men than women, more frequent in people born in cities & migrants
 Environmental & social factors implicated in increased risk

WHAT CAUSES SCHIZOPHRENIA?

Genes  Greatest risk factor – positive family history
 Life-time risk: in general population 1%; first degree relatives of
patients 6.5%; monozygotic twins of affected people > 40%
 Likely that many risk genes exist – each with a small effect
 Patients probably inherit several risk genes, which interact with
each other & the environment to cause schizophrenia

Environment  Risk factors: premature birth, low birth weight, perinatal hypoxia
 During adulthood: social isolation, migrant status, urban life
 Patients with supportive parents do much better than those with
critical / hostile ones
 Suggests interaction between biological, psychological, social risk
factors

Drug abuse  Stimulants like cocaine & amphetamines can induce picture clinically
identical to paranoid schizophrenia
 Early cannabis use – increases future risk of schizophrenia (2 to 4 times
increased risk)
 Only small portion of people who use cannabis develop
schizophrenia
 Reflects genetically determined vulnerability to environmental
stressor
 Variations in dopamine metabolising COMT gene affect propensity

, to develop psychosis in people who use cannabis

EARLY DIAGNOSIS & MANAGEMENT IN PRIMARY CARE

 Initially most patients have symptoms such as anxiety, depression, social problems,
changes in behaviour, difficulties concentrating, becoming withdrawn from normal
social life
 Onset of psychosis suspected  referral to secondary care (e.g., local early intervention
team)
 Assessment of risk that patients post to themselves & others
 Presence of psychotic symptoms confirmed  prescription of antipsychotic by GP
o Usually oral atypical antipsychotic e.g., risperidone, olanzapine in low doses


Importance of  The longer mean duration of untreated psychosis the worse the
early recognition outcome
 Patients with psychotic symptoms should be identified & treated
ASAP

Long term  Recovery from acute episode of schizophrenia  remain on prophylactic
management in doses of antipsychotic for 1-2 years & continue to be supervised by
primary care specialist services
 Well & symptom free after that time  gradual reduction of drug dose
& careful monitoring to detect any signs of relapse
 Referral back to secondary care due to: (1) poor treatment
compliance, (2) poor treatment response, (3) ongoing substance
misuse, (4) increase in risk profile

TREATMENTS IN SECONDARY CARE

Pharmacologica  First line drug – oral atypical antipsychotic
l  Except for clozapine they are no more effective than older
typical drugs
 Change from typical to atypical drug if patients exhibits many
side effects
 Lowest effective dose should be used
 Anticholinergic drugs shouldn’t be routinely prescribed due to adverse
effects on cognition & memory
 Clozapine – best drug for 20-30% of treatment resistant patients
 Only drug that can reduce positive & negative symptoms in
these patients

Psychological  Availability often limited – lack of trained therapists
 CBT can reduce persistent symptoms & improve insight: ≥ 10

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller emma2296. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for CA$5.28. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

67096 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
CA$5.28
  • (0)
  Add to cart